Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure


Creative Commons License

Tasal A., DEMİR M. , KANADAŞI M. , BACAKSIZ A., Vatankulu M. A. , Sahin D. Y. , et al.

MEDICAL SCIENCE MONITOR, cilt.20, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 20
  • Basım Tarihi: 2014
  • Doi Numarası: 10.12659/msm.889767
  • Dergi Adı: MEDICAL SCIENCE MONITOR

Özet

Background: Levosimendan (LS) is a novel inodilator that improves cardiac performance, central hemodynamics, and symptoms of patients with decompensated chronic heart failure. The aim of this study was to compare the effects of single and repeated LS infusion on left ventricular performance, biomarkers, and neurohormonal activation in patients with acute heart failure.